DTaP-IPV-Hib

DTaP-IPV/Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate (tetanus toxoid conjugate) vaccine. It is also known as DTaP-IPV/Hib or DTaP-IPV-Hib. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type B. DTaP-IPV/Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate (tetanus toxoid conjugate) vaccine. It is also known as DTaP-IPV/Hib or DTaP-IPV-Hib. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type B. A branded formulation marketed in the USA is Pentacel, manufactured by Sanofi Pasteur. Pentacel is known in the UK and Canada as Pediacel. An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine. Pentaxim is a liquid formulation marketed by Sanofi Pasteur.